STORY 01 OF 05 · CLINICAL
CLINICALPHASE 3 · ONCOLOGY
Phase 3 Ops Lead placed in 6 days.
Every week without the right expert is runway I can't recover. Peritia scaled our monitoring across 14 countries in under a month.
— VP CLINICAL OPERATIONS · SERIES B · PHASE 3 · CARDIOVASCULAR
6d
Days to match · vs 94d traditional
14
Countries deployed · 22 CRAs
STORY 02 OF 05 · REGULATORY
REGULATORYBLA · MID-PHARMA
BLA strategist inside agency in 72 hours.
A bad submission strategy doesn't just delay — it compromises. Peritia had three ex-agency strategists on deck inside 48 hours.
— HEAD OF REGULATORY · MID-PHARMA · BLA FILING
3
Ex-agency candidates returned
100%
Prior agency review experience
STORY 03 OF 05 · EVIDENCE
EVIDENCEHEOR · LAUNCH
HEOR team in three markets.
Peritia's HEOR lead shaped the payer story for our launch in three markets simultaneously — something our in-house team couldn't have covered.
— CHIEF COMMERCIAL OFFICER · SPECIALTY PHARMA
3×
Markets covered simultaneously
2
Dossiers shipped to payers
STORY 04 OF 05 · TALENT
TALENTINTERIM · GENE THERAPY
Interim CMO seated through approval.
Our CMO left six months before BLA. Peritia seated an interim CMO in nine days — and she stayed through approval.
— CEO · CLINICAL-STAGE BIOTECH
9mo
Engagement through approval
1
Approval delivered on time
STORY 05 OF 05 · STRATEGY
STRATEGYPRE-S1 · SERIES C
Investor advisor placed pre-S1.
Fourteen days before S1 drafting, we added a senior advisor who had been through it twice before. The drafting cycle didn't slip.
— CFO · SERIES C BIOTECH